ERBB2 and breast cancer: The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) have periodically issued and updated the HER2 testing guidelines in breast cancers, with first version released in 2007, first revised in 2013 and focused updated in 2018.